| Total (N = 23,835) |  | Arrhythmias (N = 1,991) |  | ||||
---|---|---|---|---|---|---|---|---|
Non-arrhythmia (N = 21,844) | Arrhythmias (N = 1,991) | P value | Atrial tachyarrhythmias (N = 425) | Ventricular tachyarrhythmias (N = 811) | Bradyarrhythmias (N = 581) | ≥ 2 kinds of arrhythmias (N = 174) | P value | |
Age (yrs) | 60.22 ± 11.28 | 62.92 ± 11.26 | < 0.001 | 66.99 ± 9.45 | 59.67 ± 11.65 | 64.20 ± 10.59 | 63.86 ± 11.42 | < 0.001 |
Male (n, %) | 16,868 (77.2%) | 1,516 (76.1%) | 0.28 | 304 (71.5%) | 652 (80.4%) | 427 (73.5%) | 133 (76.4%) | 0.002 |
BMI | 24.35 ± 3.14 | 24.02 ± 3.04 | < 0.001 | 23.80 ± 2.80 | 24.15 ± 3.13 | 24.06 ± 3.12 | 23.82 ± 2.90 | 0.21 |
Current smoker (n, %) | 10,448 (48.1%) | 896 (45.1%) | 0.01 | 151 (35.5%) | 414 (51.0%) | 249 (43.1%) | 82 (47.1%) | < 0.001 |
Family history (n, %) | 853 (3.9%) | 73 (3.7%) | 0.58 | 12 (2.8%) | 41 (5.1%) | 18 (3.1%) | 2 (1.1%) | 0.02 |
Comorbidities | Â | Â | Â | Â | Â | Â | Â | Â |
Hypertension (n, %) | 10,459 (48.0%) | 995 (50.1%) | 0.08 | 225 (52.9%) | 392 (48.4%) | 301 (52.0%) | 77 (44.3%) | 0.14 |
Hyperlipidemia (n, %) | 1,934 (8.9%) | 125 (6.3%) | < 0.001 | 18 (4.2%) | 57 (7.0%) | 44 (7.6%) | 6 (3.4%) | 0.04 |
Diabetes mellitus (n, %) | 4,041 (18.6%) | 373 (18.8%) | 0.82 | 87 (20.5%) | 125 (15.5%) | 127 (22.0%) | 34 (19.5%) | 0.01 |
CKD (n, %) | 202 (0.9%) | 32 (1.6%) | 0.007 | 5 (1.2%) | 15 (1.9%) | 5 (0.9%) | 7 (4.0%) | 0.05 |
Medical History | Â | Â | Â | Â | Â | Â | Â | Â |
Previous angina pectoris (n, %) | 4,925 (26.1%) | 480 (26.1%) | 0.97 | 108 (27.7%) | 203 (27.0%) | 127 (23.6%) | 42 (26.3%) | 0.45 |
Previous PCI/CABG (n, %) | 1,080 (5.7%) | 95 (5.2%) | 0.33 | 18 (4.6%) | 47 (6.3%) | 21 (3.9%) | 9 (5.6%) | 0.27 |
Previous MI (n, %) | 1,439 (7.6%) | 170 (9.0%) | 0.02 | 33 (8.5%) | 91 (12.1%) | 31 (5.8%) | 15 (9.3%) | < 0.001 |
Previous HF (n, %) | 331 (1.5%) | 73 (3.7%) | < 0.001 | 24 (5.6%) | 26 (3.2%) | 14 (2.4%) | 9 (5.2%) | 0.04 |
Previous Stroke (n, %) | 1,719 (7.9%) | 248 (12.5%) | < 0.001 | 68 (16.0%) | 79 (9.8%) | 82 (14.2%) | 19 (10.9%) | 0.007 |
Previous PAD (n, %) | 141 (0.6%) | 8 (0.4%) | 0.16 | 2 (0.5%) | 2 (0.2%) | 1 (0.2%) | 3 (1.7%) | 0.12 |
Clinical characteristics | Â | Â | Â | Â | Â | Â | Â | Â |
STEMI (n, %) | 16,487 (75.5%) | 1,658 (83.3%) | < 0.001 | 299 (70.4%) | 697 (85.9%) | 517 (89.0%) | 145 (83.3%) | < 0.001 |
LVEF (%) | 54.30 ± 9.88 | 51.57 ± 10.75 | < 0.001 | 50.57 ± 11.15 | 50.16 ± 10.81 | 54.89 ± 9.45 | 49.72 ± 11.31 | < 0.001 |
LVEDD (mm) | 49.17 ± 12.07 | 49.82 ± 9.07 | 0.01 | 50.44 ± 9.87 | 49.87 ± 9.75 | 48.96 ± 7.60 | 51.05 ± 7.41 | 0.07 |
Killip classification III-IV (n, %) | 832 (3.8%) | 297 (15.0%) | < 0.001 | 62 (14.6%) | 120 (14.9%) | 76 (13.1%) | 39 (22.4%) | 0.04 |
Treatments | Â | Â | Â | Â | Â | Â | Â | Â |
PCI (n, %) | 8,306 (38.0%) | 800 (40.2%) | 0.27 | 130 (30.6%) | 374 (46.1%) | 234 (40.3%) | 62 (35.6%) | 0.18 |
CABG (n, %) | 25 (0.1%) | 2 (0.1%) | 0.92 | 0 | 1 (0.1%) | 1 (0.2%) | 0 | 0.73 |
Fibrinolysis (n, %) | 1,752 (8.0%) | 254 (12.8%) | < 0.001 | 34 (8.0%) | 128 (15.8%) | 69 (11.9%) | 23 (13.2%) | 0.28 |